Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children
Abstract Background The prescribing of antidepressants and antipsychotics to children has increased worldwide, but little is known about how changes in drug funding policy influence the practice. In 2018, Ontario introduced a universal pharmacare program (OHIP+) for children and youth, amending it i...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12887-024-05345-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1823861614252654592 |
---|---|
author | Sophie A. Kitchen Tara Gomes Mina Tadrous Kathleen Pajer William Gardner Yona Lunsky Melanie Penner David Juurlink Muhammad Mamdani Tony Antoniou |
author_facet | Sophie A. Kitchen Tara Gomes Mina Tadrous Kathleen Pajer William Gardner Yona Lunsky Melanie Penner David Juurlink Muhammad Mamdani Tony Antoniou |
author_sort | Sophie A. Kitchen |
collection | DOAJ |
description | Abstract Background The prescribing of antidepressants and antipsychotics to children has increased worldwide, but little is known about how changes in drug funding policy influence the practice. In 2018, Ontario introduced a universal pharmacare program (OHIP+) for children and youth, amending it in April 2019 to cover only those without private insurance. We examined the association of these policy changes with antipsychotic and antidepressant medication prescribing. Methods We conducted a population-based study of antidepressant and antipsychotic medication dispensing to children ≤ 18 years old between September 1, 2014, and February 29, 2020. We obtained dispensing data from the IQVIA Geographic Prescription Monitor database, and used interventional autoregressive integrated moving average models to examine whether the implementation of OHIP + and its subsequent revision were associated with changes in dispensing. Results The implementation of OHIP + was not associated with changes in the rate of antidepressants (-19.3 units per 1,000 population; 95% confidence interval [CI]: -41.7 to 3.1) or antipsychotics (+ 1.0 unit per 1,000 population; 95% CI: -5.4 to 7.5) dispensed. Similarly, subsequent changes to the program restricting coverage to children without private insurance were not associated with antidepressant (0.3 units per 1,000; 95% CI: -7.4 to 7.9) or antipsychotic (1.0 units per 1,000; 95% CI: -0.9 to 2.9) dispensing trends. Conclusion Implementation of a publicly-funded pharmacare program did not influence trends in antidepressant or antipsychotic medication dispensing among children. |
format | Article |
id | doaj-art-06c342096e554adc8df8ed34edb74552 |
institution | Kabale University |
issn | 1471-2431 |
language | English |
publishDate | 2025-02-01 |
publisher | BMC |
record_format | Article |
series | BMC Pediatrics |
spelling | doaj-art-06c342096e554adc8df8ed34edb745522025-02-09T12:54:29ZengBMCBMC Pediatrics1471-24312025-02-012511910.1186/s12887-024-05345-2Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to childrenSophie A. Kitchen0Tara Gomes1Mina Tadrous2Kathleen Pajer3William Gardner4Yona Lunsky5Melanie Penner6David Juurlink7Muhammad Mamdani8Tony Antoniou9ICESICESICESDepartment of Psychiatry, University of OttawaICESICESAutism Research Centre, Bloorview Research Institute, Holland Bloorview Kids Rehabilitation HospitalICESICESICESAbstract Background The prescribing of antidepressants and antipsychotics to children has increased worldwide, but little is known about how changes in drug funding policy influence the practice. In 2018, Ontario introduced a universal pharmacare program (OHIP+) for children and youth, amending it in April 2019 to cover only those without private insurance. We examined the association of these policy changes with antipsychotic and antidepressant medication prescribing. Methods We conducted a population-based study of antidepressant and antipsychotic medication dispensing to children ≤ 18 years old between September 1, 2014, and February 29, 2020. We obtained dispensing data from the IQVIA Geographic Prescription Monitor database, and used interventional autoregressive integrated moving average models to examine whether the implementation of OHIP + and its subsequent revision were associated with changes in dispensing. Results The implementation of OHIP + was not associated with changes in the rate of antidepressants (-19.3 units per 1,000 population; 95% confidence interval [CI]: -41.7 to 3.1) or antipsychotics (+ 1.0 unit per 1,000 population; 95% CI: -5.4 to 7.5) dispensed. Similarly, subsequent changes to the program restricting coverage to children without private insurance were not associated with antidepressant (0.3 units per 1,000; 95% CI: -7.4 to 7.9) or antipsychotic (1.0 units per 1,000; 95% CI: -0.9 to 2.9) dispensing trends. Conclusion Implementation of a publicly-funded pharmacare program did not influence trends in antidepressant or antipsychotic medication dispensing among children.https://doi.org/10.1186/s12887-024-05345-2AntidepressantAntipsychotic agentsChildAdolescentTime-series analysisPolicy analysis |
spellingShingle | Sophie A. Kitchen Tara Gomes Mina Tadrous Kathleen Pajer William Gardner Yona Lunsky Melanie Penner David Juurlink Muhammad Mamdani Tony Antoniou Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children BMC Pediatrics Antidepressant Antipsychotic agents Child Adolescent Time-series analysis Policy analysis |
title | Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children |
title_full | Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children |
title_fullStr | Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children |
title_full_unstemmed | Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children |
title_short | Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children |
title_sort | association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children |
topic | Antidepressant Antipsychotic agents Child Adolescent Time-series analysis Policy analysis |
url | https://doi.org/10.1186/s12887-024-05345-2 |
work_keys_str_mv | AT sophieakitchen associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren AT taragomes associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren AT minatadrous associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren AT kathleenpajer associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren AT williamgardner associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren AT yonalunsky associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren AT melaniepenner associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren AT davidjuurlink associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren AT muhammadmamdani associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren AT tonyantoniou associationbetweenapubliclyfundeduniversaldrugprogramandantipsychoticandantidepressantmedicationdispensingtochildren |